Necrotizing pneumonia in the community

Internal Medicine

Volumn 51, Issue 17, 2012, Pages 2463-2467

  Otera, Hiroshi ^a   Yamamoto, Go ^a   Ohkusu, Kiyofumi ^b   Kozuki, Haruka ^a   Hashimoto, Kimio ^a   Tada, Kimihide ^a  

^a NISHI KOBE MEDICAL CENTER   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Methicillin resistant Staphylococcus aureus; Necrotizing pneumonia; Panton valentine leukocidin

Indexed keywords

BETA LACTAM ANTIBIOTIC; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; ERYTHROMYCIN; HABEKACIN; MEROPENEM; NORADRENALIN; OXACILLIN; OXYGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TOXIC SHOCK SYNDROME TOXIN 1; VANCOMYCIN;

ADULT; ARTICLE; ATELECTASIS; AUTOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS LEVEL; DEATH; FATIGUE; HUMAN; HUMAN TISSUE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NECROTIZING PNEUMONIA; PHYSICAL EXAMINATION; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; REAL TIME POLYMERASE CHAIN REACTION; SEPTIC SHOCK; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; FATAL OUTCOME; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NECROSIS; PNEUMONIA, STAPHYLOCOCCAL; STAPHYLOCOCCAL INFECTIONS; TREATMENT FAILURE; VANCOMYCIN;

EID: 84867758852     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7626     Document Type: Article

References (21)

1. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated Methicillin-resistant Staphylococcus aureus infection. JAMA 290: 2976-2984, 2003.
2. Klevens RM, Morrison MA, Nadle J, et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators: Invesive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771, 2007.
3. Hidron AI, Low CE, Honig EG, Blumberg HM. Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 9: 384-392, 2009.
4. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillinresistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 35: 819-824, 2002.
5. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet Infect Dis 359: 753-759, 2002.
6. Que YA, Moreillon P. Staphylococcus aureus (including Staphylococcal toxic shock). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases - Expert Consult Premium ed. 7th ed. Mandell GL, Bennett JE, Dolin R, Eds. Churchill Livingstone, Philadelphia, 2010: 2543-2578.
7. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton- Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9: 978-984, 2003.
8. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureusan emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 16: 103-124, 2003. Review.
9. Diep BA, Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 16: 361-369, 2008.
10. Löffler B, Hussain M, Grundmeier M, et al. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6: e1000715, 2010.
11. Yamamoto T, Nishiyama A, Takano T, et al. Community-acquired methicilin-resistant Staphyrococcus aureus: community transmission, pathogenesis, and drug resistance. J Infect Chemother 16: 225-254, 2010.
12. Yamamoto T, Dohmae S, Saito K, et al. Molecular characteristics and in vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of Panton-Valentine leucocidinpositive methicillin-resistant Staphylococcus aureus isolates from the community and hospitals. Antimicrob Agents Chemother 50: 4077-4086, 2006.
13. Hisata K, Kuwahara-Arai K, Yamanoto M, et al. Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J Clin Microbiol 43: 3364-3372, 2005.
14. Ito T, Iijima M, Fukushima T, et al. Pediatric pneumonia death caused by community-acquired Methicillin-resistant Staphylococcus aureus, Japan. Emerg Infect Dis 14: 1312-1314, 2008.
15. Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with Methicillin-Resistant Staphylococcus aureus. Clin Infect Dis 48: 910-913, 2009.
16. Tomita Y, Kawano O, Ichiyasu H, et al. Two cases of severe necrotizing pneumonia caused by community-acquired methicillinresistant Staphylococcus aureus. Nihon Kokyuki Gakkai Zasshi 46: 395-403, 2008 (in Japanese, Abstract in English).
17. Orii KO, Iwao Y, Higuchi W, Takano T, Yamamoto T. Molecular characterization of methicillin-resistant Staphylococcus aureus from a fatal case of necrotizing fasciitis in an extremely low-birthweight infant. Clin Microbiol Infect 16: 289-292, 2010.
18. Tofte RW, Williams DN. Toxic shock syndrome. Evidence of a broad clinical spectrum. JAMA 246: 2163-2167, 1981.
19. Parsonnet J. Case definition of staphylococcal TSS: a proposed revision incorporating laboratory findings. In: International Congress and Syndrome. Arbuthnott J, Furman B, Eds. Royal Society of Medicine Press, London, 1998: 15-16.
20. Hageman JC, Uyeki TM, Francis JS, et al. Severe communityacquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 12: 894-899, 2006.
21. Saito A, Kohno S, Matsushima T, et al. Study Group. Prospective multicenter study of the causative organisms of communityacquired pneumonia in adults in Japan. J Infect Chemother 12: 63-69, 2006.